EE497 The Cost-Effectiveness of Semaglutide 2.4MG in Patients With Overweight/Obesity and Cardiovascular Disease From the Select Trial
Abstract
Authors
P McEwan M Bøg M Faurby V Foos I Lingvay C Lübker R Miller J Toliver F Yeates A.M. Lincoff